Short Interest in Tema Cardiovascular and Metabolics ETF (NASDAQ:HRTS) Grows By 180.0%

Tema Cardiovascular and Metabolics ETF (NASDAQ:HRTS) saw a large increase in short interest during the month of November. As of November 15th, there was short interest totalling 1,400 shares, an increase of 180.0% from the October 31st total of 500 shares. Based on an average daily trading volume, of 14,600 shares, the short-interest ratio is currently 0.1 days.

Institutional Trading of Tema Cardiovascular and Metabolics ETF

A hedge fund recently raised its stake in Tema Cardiovascular and Metabolics ETF stock. Sterling Investment Advisors Ltd. raised its stake in Tema Cardiovascular and Metabolics ETF (NASDAQ:HRTS) by 20.6% in the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 153,090 shares of the company’s stock after acquiring an additional 26,130 shares during the period. Tema Cardiovascular and Metabolics ETF accounts for about 1.4% of Sterling Investment Advisors Ltd.’s investment portfolio, making the stock its 20th biggest holding. Sterling Investment Advisors Ltd. owned about 6.03% of Tema Cardiovascular and Metabolics ETF worth $5,104,000 as of its most recent filing with the Securities & Exchange Commission.

Tema Cardiovascular and Metabolics ETF Stock Up 1.3 %

Shares of HRTS opened at $32.33 on Thursday. Tema Cardiovascular and Metabolics ETF has a 52-week low of $26.38 and a 52-week high of $36.03. The firm has a market cap of $80.18 million, a price-to-earnings ratio of 32.89 and a beta of 0.93. The business’s 50 day moving average is $33.19 and its two-hundred day moving average is $33.47.

Tema Cardiovascular and Metabolics ETF Company Profile

The Tema Obesity & Cardiometabolic ETF (HRTS) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed fund that concentrates on companies focused on the treatment of cardiovascular diseases and/or metabolic diseases from companies all around the world. Using both top-down and bottom-up stock selection, the fund identifies innovative companies deemed attractive.